Barely Significant
← all excerpts

Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy.

Vaccines (Basel) · 2024 · PMC11053591 · PMID 38675738

Europe PMCDOI
1
hedged sentence
0.0598
closest p · 1.2× alpha
0.0598
boldest claim

The sentences

did not reach statistical significancep = 0.0598so close (0.05 < p ≤ 0.1)
However, the difference between the median overall survival times of stage IV and stage III long-term survivors did not reach statistical significance ( p = 0.0598; Figure 2 DIII).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.